BaileyK. Detecting fabrication of data in a multicenter collaborative animal study. Control Clin Trials1991; 12: 741–52.
2.
ChristianMMcCabeMKornE. The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project B-06. N Engl J Med1995; 333: 1469–74.
3.
ChenZMJiangLXChenYP.; COMMIT (CLOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: Randomized placebo-controlled trial. Lancet2005; 366: 1607–21.
4.
DevereauxPYangHYusufS. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet2008; 371: 1839–47.
5.
NeatonJBartschGBrosteS.; for the MRFIT Research Group. A case of data alteration in the Multiple Risk Factor Intervention Trial (MRFIT). Control Clin Trials1991; 12: 731–40.
6.
PetoRCollinsRSackettD. The trials of Dr. Bernard Fisher: A European perspective on an American episode. Control Clin Trials1997; 18: 1–13.
7.
The EsPS2 Group. European Stroke Prevention Study 2. Efficacy and safety data. J Neurol Sci1997; 151: S1–77.
8.
Al-MarzoukiSEvansSMarshallTRobertsI. Are these data real? Statistical methods for the detection of data fabrication in clinical trials. BMJ2005; 331: 267–70.
9.
BuyseMGeorgeSEvansS.; for the ISCB Subcommittee on Fraud. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med1999; 18: 3435–51.
10.
DeMetsD. Distinctions between fraud, bias, errors, misunderstanding, and incompetence. Clin Trials1997; 18: 637–50.
11.
EvansS. Statistical aspects of the detection of fraud. In LockSWellsF (eds). Fraud and Misconduct in Medical Research. BMJ Publishing Group, London, 1996, pp. 226–39.
12.
KnatterudGRockholdFGeorgeS. Guidelines for quality assurance in multicenter trials: A position paper. Control Clin Trials1998; 19: 477–93.
13.
PogueJDevereauxPThorlandKYusufS. Central statistical monitoring: Detecting fraud in clinical trials. Clin Trials2013; 10: 225–35.
14.
TaylorRMcEntegartDStillmanE. Statistical techniques to detect fraud and other data irregularities in clinical questionnaire data. Drug Inf J2002; 36: 115–25.
15.
BaigentCHarrellFBuyseMEmbersonJRAltmanDG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials2008; 5: 49–55.
16.
LederbergJ. Sloppy research exacts a greater toll than misconduct. The Scientist, 20February1995, vol. 9, p. 13.
